The world of orphan drugs is at the cusp of a transformation in the post COVID era. In this episode, the team discuss the impact of the pandemic on value demonstration of orphan drugs. In order to be successful, manufacturers of precision medicine will need to focus on carving out a niche for their drugs and support health systems to find the right patient for their treatment at the right time.
The team also explore the role of digital tools such as Artificial Intelligence (AI) and telemedicine in helping drugmakers optimise manufacturing and treatment delivery. This combined with a multi-stakeholder approach will provide the recipe for success for next generation`niche-busters'.
Presenter and Contributor : Akshay Kumar
Other contributors: Richard Wang, Andrea Bernardini and Erfan Akbraian
Producer: Aparna Krishnan
Weekly Roundup: November 5, 2019
Weekly RoundUp: August 5, 2019
Weekly Roundup: July 29, 2019
Weekly Roundup: July 22, 2019
Weekly Roundup: July 1, 2019
Weekly Roundup: June 23, 2019
Weekly Roundup: June 16, 2019
Weekly Roundup: June 12, 2019
Weekly RoundUp: June 3, 2019
Weekly Roundup: May 25, 2019
Weekly Roundup: May 18, 2019
Weekly Roundup: May 12, 2019
Weekly Roundup: May 3, 2019
Weekly Roundup: April 27, 2019
Weekly Roundup: April 22, 2019
Weekly Roundup: April 12, 2019
Weekly Roundup: March 28, 2019
Weekly Roundup: March 22, 2019
Weekly Roundup: March 15, 2019
Weekly Roundup: March 8, 2019
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Museum of the Missing
Strange by Nature Podcast
Sasquatch Chronicles
Hidden Brain